Emergency Briefing: “The Great Reset”
By May 28th, Americans could be faced with a difficult choice: Accept a "Great Reset" and risk losing the American way of life... or stand up and fight back to save what's left of the American dream. Jeff Brown, a member of a D.C.-based advocacy group, explains what every American must do before May 28th to preserve his assets and thrive.
Click here to see this emergency briefing before i

NGM Insider Trading (NGM Biopharmaceuticals)

Insider Ownership Percentage: 50.40%
Insider Buying (Last 12 Months): $3,409,280.89
Insider Selling (Last 12 Months): $4,018,364.00

NGM Biopharmaceuticals Insider Trading History Chart

NGM Biopharmaceuticals Share Price & Price History

$25.43
▼ -0.97 (-3.67%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel

NGM Biopharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2021Jin-Long ChenInsiderSell25,000$26.66$666,500.00970,005  
1/4/2021Jin-Long ChenInsiderSell25,000$29.28$732,000.00870,375  
12/14/2020Jin-Long ChenInsiderSell25,000$28.01$700,250.00908,879  
10/12/2020Jin-Long ChenInsiderSell25,000$17.02$425,500.00945,005  
9/1/2020Group L P ColumnDirectorBuy36,494$17.64$643,754.16  
9/1/2020Jin-Long ChenInsiderSell25,000$17.83$445,750.00977,618  
8/27/2020Group L P ColumnDirectorBuy36,359$17.79$646,826.61  
8/24/2020Group L P ColumnDirectorBuy11,024$17.96$197,991.04  
8/21/2020Group L P ColumnDirectorBuy7,321$17.97$131,558.37  
8/17/2020Group L P ColumnDirectorBuy6,425$17.89$114,943.25  
8/13/2020Group L P ColumnDirectorBuy19,895$17.89$355,921.55  
7/30/2020Group L P ColumnDirectorBuy732$17.99$13,168.68  
7/27/2020Group L P ColumnDirectorBuy3,834$17.99$68,973.66  
7/24/2020Group L P ColumnDirectorBuy68,749$17.93$1,232,669.57  
7/22/2020Group L P ColumnDirectorBuy193$18.00$3,474.00  
7/1/2020Jin-Long ChenInsiderSell25,000$18.91$472,750.001,027,268  
6/15/2020Jin-Long ChenInsiderSell25,000$21.65$541,250.00  
5/15/2020Hsiao D. LieuSVPSell1,562$22.00$34,364.00  
4/7/2020Group L P ColumnMajor ShareholderBuy138,315$14.19$1,962,689.85  
4/7/2020Peter SvennilsonDirectorBuy123,728$14.38$1,779,208.6420,000  
4/2/2020Group L P ColumnMajor ShareholderBuy250,984$12.78$3,207,575.52  
4/2/2020Peter SvennilsonDirectorBuy14,850$12.40$184,140.0020,000  
3/31/2020Peter SvennilsonDirectorBuy118,067$12.53$1,479,379.5120,000  
3/25/2020Group L P ColumnMajor ShareholderBuy301,180$13.33$4,014,729.40  
3/25/2020Peter SvennilsonDirectorBuy2,416$12.49$30,175.8420,000  
3/23/2020Peter SvennilsonDirectorBuy170,387$11.63$1,981,600.8120,000  
3/20/2020Group L P ColumnMajor ShareholderBuy143,082$11.77$1,684,075.14  
3/19/2020Peter SvennilsonDirectorBuy148,464$11.59$1,720,697.7620,000  
3/5/2020Peter SvennilsonDirectorBuy8,307$18.00$149,526.0020,000  
3/4/2020Group L P ColumnMajor ShareholderBuy9,986$17.96$179,348.56  
3/3/2020Peter SvennilsonDirectorBuy38,758$17.99$697,256.4220,000  
3/2/2020Group L P ColumnMajor ShareholderBuy14,124$17.90$252,819.60  
2/28/2020Group L P ColumnMajor ShareholderBuy75,447$18.04$1,361,063.88  
2/27/2020Peter SvennilsonDirectorBuy33,896$17.91$607,077.3620,000  
2/26/2020Group L P ColumnMajor ShareholderBuy3,751$18.00$67,518.00  
2/6/2020Group L P ColumnMajor ShareholderBuy44,900$15.47$694,603.00  
1/9/2020Jin-Long ChenInsiderSell18,641$17.95$334,605.951,012,783  
1/7/2020Jin-Long ChenInsiderSell16,090$18.20$292,838.001,012,783  
11/11/2019Peter SvennilsonDirectorBuy15$12.00$180.0020,000  
11/4/2019Jin-Long ChenInsiderSell50,765$12.67$643,192.55
11/4/2019Peter SvennilsonDirectorBuy8,409$13.01$109,401.09
10/23/2019Peter SvennilsonDirectorBuy4,387$13.54$59,399.98
10/21/2019Group L P ColumnMajor ShareholderSell30,926$77.72$2,403,568.72
10/21/2019Peter SvennilsonDirectorBuy84,939$11.75$998,033.25
10/16/2019David V GoeddelDirectorBuy11,000$3.10$34,100.00
10/16/2019Group L P ColumnMajor ShareholderBuy103,000$10.87$1,119,610.00
10/14/2019Group L P ColumnMajor ShareholderSell20,000$1.41$28,200.00
10/11/2019Group L P ColumnMajor ShareholderBuy53,172$10.38$551,925.36
8/9/2019Group L P ColumnMajor ShareholderBuy224,664$14.00$3,145,296.00  
8/6/2019David V GoeddelDirectorBuy6,134$13.98$85,753.32  
8/2/2019Group L P ColumnMajor ShareholderBuy4,382$13.98$61,260.36  
7/30/2019Peter SvennilsonDirectorBuy28,056$13.68$383,806.08  
7/26/2019David V GoeddelDirectorBuy89,866$13.49$1,212,292.34  
7/23/2019Group L P ColumnMajor ShareholderBuy67,742$13.49$913,839.58  
7/16/2019Group L P ColumnMajor ShareholderBuy20,088$13.72$275,607.36  
7/12/2019Group L P ColumnMajor ShareholderBuy31,884$13.88$442,549.92  
6/24/2019Group L P ColumnMajor ShareholderBuy12,240$13.78$168,667.20  
6/21/2019Group L P ColumnMajor ShareholderBuy34,377$13.90$477,840.30  
6/14/2019Peter SvennilsonDirectorBuy29,760$14.05$418,128.00  
6/11/2019Group L P ColumnMajor ShareholderBuy23,500$13.74$322,890.00  
6/6/2019Group L P ColumnMajor ShareholderBuy25,200$13.40$337,680.00  
5/20/2019Group L P ColumnMajor ShareholderBuy50,000$13.50$675,000.00  
5/10/2019Group L P ColumnMajor ShareholderBuy17,923$13.85$248,233.55  
5/7/2019Peter SvennilsonDirectorBuy57,000$14.10$803,700.00  
4/8/2019Merck & Co., Inc.Major ShareholderBuy4,121,683$16.00$65,946,928.00  
4/8/2019Suzanne Sawochka HooperDirectorBuy7,000$16.00$112,000.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

49.56% of NGM Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NGM Biopharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/12/2021DekaBank Deutsche Girozentrale21,100$0.65M0.0%-5.0%0.031%
3/8/2021Dimensional Fund Advisors LP70,932$2.15M0.0%+46.5%0.103%
2/25/2021Dimensional Fund Advisors LP70,932$2.15M0.0%+46.5%0.103%
2/25/2021Hsbc Holdings PLC11,302$0.34M0.0%-26.4%0.016%
2/23/2021Principal Financial Group Inc.14,214$0.43M0.0%-71.0%0.021%
2/19/2021JPMorgan Chase & Co.192,094$5.82M0.0%-5.4%0.278%
2/18/2021Verition Fund Management LLC165,628$5.02M0.0%N/A0.240%
2/17/2021Jane Street Group LLC7,066$0.21M0.0%N/A0.010%
2/17/2021Samsara BioCapital LLC18,225$0.55M0.1%-50.0%0.026%
2/16/2021Squarepoint Ops LLC20,618$0.63M0.0%N/A0.030%
2/16/2021Morgan Stanley210,283$6.37M0.0%+37.4%0.305%
2/16/2021Baker BROS. Advisors LP106,616$3.23M0.0%-9.7%0.154%
2/16/2021Nuveen Asset Management LLC99,980$3.03M0.0%+6.5%0.145%
2/16/2021Engineers Gate Manager LP33,731$1.02M0.0%-23.8%0.049%
2/16/2021Charles Schwab Investment Management Inc.131,499$3.98M0.0%+1.4%0.191%
2/13/2021American International Group Inc.13,861$0.42M0.0%-2.8%0.020%
2/12/2021Penserra Capital Management LLC1,585$48K0.0%+169.6%0.002%
2/12/2021The Manufacturers Life Insurance Company 15,518$0.47M0.0%+3.0%0.022%
2/12/2021Virtus ETF Advisers LLC10,685$0.32M0.1%-28.2%0.015%
2/11/2021Northern Trust Corp269,472$8.16M0.0%-2.3%0.390%
2/11/2021Barclays PLC16,238$0.49M0.0%-36.1%0.024%
2/11/2021Citigroup Inc.7,341$0.22M0.0%+40.7%0.011%
2/10/2021Rhumbline Advisers29,352$0.89M0.0%+6.8%0.043%
2/9/2021Wells Fargo & Company MN35,978$1.09M0.0%-29.6%0.052%
2/9/2021Bank of New York Mellon Corp83,155$2.52M0.0%-2.2%0.120%
2/9/2021Princeton Global Asset Management LLC1,600$48K0.0%N/A0.002%
2/9/2021ProShare Advisors LLC15,931$0.48M0.0%+13.7%0.023%
2/8/2021Alliancebernstein L.P.29,800$0.90M0.0%-4.5%0.043%
2/8/2021Beacon Investment Advisory Services Inc.7,071$0.21M0.0%N/A0.010%
2/8/2021Russell Investments Group Ltd.33,962$1.03M0.0%-4.7%0.049%
2/5/2021BlackRock Inc.2,525,616$76.51M0.0%+3.3%3.659%
2/5/2021Aperio Group LLC10,526$0.32M0.0%N/A0.015%
2/5/2021SG Americas Securities LLC28,375$0.86M0.0%+142.5%0.041%
2/4/2021Cambridge Investment Research Advisors Inc.8,306$0.25M0.0%N/A0.012%
2/4/2021GSA Capital Partners LLP46,908$1.42M0.2%N/A0.068%
2/4/2021State of Wisconsin Investment Board33,500$1.02M0.0%-11.1%0.049%
1/27/2021Exane Derivatives5,819$0.18M0.1%N/A0.008%
1/25/2021Nisa Investment Advisors LLC8,099$0.25M0.0%+175.3%0.012%
1/22/2021Candriam Luxembourg S.C.A.221,634$6.72M0.1%-3.1%0.321%
1/21/2021Cutler Group LP2,000$60K0.0%+100.0%0.003%
11/17/2020Voloridge Investment Management LLC10,328$0.16M0.0%-54.3%0.015%
11/17/2020California State Teachers Retirement System35,834$0.57M0.0%+1.2%0.052%
11/16/2020Cubist Systematic Strategies LLC8,748$0.14M0.0%-49.3%0.013%
11/16/2020Point72 Asset Management L.P.1,611,850$25.65M0.1%+5.8%2.342%
11/16/2020Samsara BioCapital LLC36,451$0.58M0.2%-25.0%0.053%
11/16/2020Weld Capital Management LLC15,238$0.24M0.1%N/A0.022%
11/16/2020Engineers Gate Manager LP44,292$0.71M0.0%-23.0%0.064%
11/13/2020Morgan Stanley153,049$2.44M0.0%-17.5%0.222%
11/13/2020Charles Schwab Investment Management Inc.129,660$2.06M0.0%+58.0%0.188%
11/13/2020Virtus ETF Advisers LLC14,880$0.24M0.1%-12.0%0.022%
11/12/2020Quilter Plc12,000$0.19M0.0%-7.7%0.017%
11/12/2020JPMorgan Chase & Co.203,014$3.27M0.0%-7.0%0.295%
11/10/2020State Street Corp441,700$7.03M0.0%-4.9%0.642%
11/9/2020SG Americas Securities LLC11,700$0.19M0.0%-85.8%0.017%
11/6/2020BlackRock Inc.2,444,439$38.89M0.0%+7.0%3.552%
11/5/2020California Public Employees Retirement System53,774$0.86M0.0%+1.5%0.078%
11/5/2020First Trust Advisors LP69,009$1.10M0.0%N/A0.100%
11/5/2020Wells Fargo & Company MN51,113$0.81M0.0%-39.0%0.074%
11/4/2020Svennilson Peter18,017,932$286.67M23.4%+1.8%26.178%
11/4/2020Raymond James Financial Services Advisors Inc.14,057$0.22M0.0%-13.5%0.020%
11/4/2020Raymond James & Associates64,282$1.02M0.0%+11.0%0.093%
10/30/2020BNP Paribas Arbitrage SA6,266$100K0.0%+455.5%0.009%
10/29/2020DekaBank Deutsche Girozentrale22,200$0.35M0.0%N/A0.032%
10/20/2020Nisa Investment Advisors LLC2,942$47K0.0%-51.7%0.004%
9/4/2020Principal Financial Group Inc.32,919$0.65M0.0%N/A0.048%
8/25/2020Nuveen Asset Management LLC112,118$2.21M0.0%-2.0%0.163%
8/20/2020Charles Schwab Investment Management Inc.82,061$1.62M0.0%+1.7%0.119%
8/17/2020Engineers Gate Manager LP57,506$1.14M0.1%+30.2%0.084%
8/17/2020California State Teachers Retirement System35,396$0.70M0.0%-6.2%0.051%
8/17/2020Jacobs Levy Equity Management Inc.199,396$3.94M0.0%+44.5%0.290%
8/14/2020Point72 Asset Management L.P.1,523,585$30.08M0.2%+52.9%2.236%
8/14/2020Bank of America Corp DE13,953$0.28M0.0%+136.7%0.020%
8/14/2020Vanguard Group Inc.1,408,979$27.81M0.0%+197.2%2.068%
8/13/2020Federated Hermes Inc.2,681$53K0.0%-18.9%0.004%
8/13/2020Marshall Wace North America L.P.22,191$0.44M0.0%-25.5%0.033%
8/12/2020Bank of Montreal Can1,881$36K0.0%+130.5%0.003%
8/12/2020Svennilson Peter17,706,978$349.54M29.2%+2.2%25.985%
8/12/2020Goldman Sachs Group Inc.60,396$1.19M0.0%+35.6%0.089%
8/12/2020Bank of New York Mellon Corp81,189$1.60M0.0%-1.3%0.119%
8/12/2020California Public Employees Retirement System52,988$1.05M0.0%+55.2%0.078%
8/5/2020Principal Financial Group Inc.32,919$0.65M0.0%N/A0.048%
8/5/2020RMB Capital Management LLC55,824$1.10M0.0%N/A0.082%
8/5/2020Virtus ETF Advisers LLC16,913$0.33M0.2%N/A0.025%
8/5/2020Russell Investments Group Ltd.41,024$0.81M0.0%+27.7%0.060%
8/3/2020ProShare Advisors LLC14,081$0.28M0.0%+32.7%0.021%
7/31/2020UBS Group AG9,589$0.19M0.0%-9.0%0.014%
7/23/2020Candriam Luxembourg S.C.A.228,764$4.52M0.0%-5.5%0.336%
7/23/2020Strs Ohio15,300$0.30M0.0%+15.0%0.022%
7/20/2020SG Americas Securities LLC82,348$1.63M0.0%+683.8%0.121%
7/17/2020Raymond James Financial Services Advisors Inc.16,254$0.32M0.0%N/A0.024%
6/19/2020State Street Corp459,052$5.66M0.0%+21.9%0.674%
6/16/2020Royal Bank of Canada933,959$11.52M0.0%-0.2%1.371%
5/15/2020Engineers Gate Manager LP44,153$0.54M0.0%N/A0.065%
5/15/2020Morgan Stanley2,887$35K0.0%-93.7%0.004%
5/14/2020Wells Fargo & Company MN37,131$0.46M0.0%+46.5%0.055%
5/14/2020Geode Capital Management LLC234,788$2.89M0.0%+25.5%0.347%
5/14/2020Legal & General Group Plc3,749$49K0.0%-25.1%0.006%
5/14/2020Deutsche Bank AG9,797$0.12M0.0%+9.1%0.014%
5/14/2020Alliancebernstein L.P.26,700$0.33M0.0%+81.6%0.039%
5/14/2020Nuveen Asset Management LLC114,438$1.41M0.0%-48.6%0.169%
Data available starting January 2016

See Full Table
NGM Biopharmaceuticals logo
NGM Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company's product candidates include Aldafermin, an engineered variant of the FGF19 human hormone in Phase 2b clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); NGM313, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase 1b clinical trial for use in the treatment of type 2 diabetes and NASH; and NGM395, which is engineered variant of the GDF15 human hormone for use in the treatment of metabolic syndrome. Its products under development also comprise NGM120, an inhibitory antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase 1 clinical trials to inhibit the effects of elevated GDF15 levels on cancer anorexia/cachexia syndrome; NGM217, an antibody in Phase 1 clinical trials to restore pancreatic islet function and increase insulin production in patients with diabetes; and NGM621, an antibody in Phase 1 clinical trials to decrease levels of a protein implicated in the dry form of AMD. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $25.43
$25.03
$26.85

50 Day Range

MA: $28.56
$25.67
$31.93

52 Week Range

Now: $25.43
$14.70
$32.12

Volume

117,212 shs

Average Volume

303,715 shs

Market Capitalization

$1.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?

NGM Biopharmaceuticals' top insider shareholders include:
  1. Jin-Long Chen (Insider)
  2. Peter Svennilson (Director)
  3. David V Goeddel (Director)
  4. Group L P Column (Director)
  5. Group L P Column (Major Shareholder)
  6. Hsiao D Lieu (SVP)
Emergency Briefing: “The Great Reset”
By May 28th, Americans could be faced with a difficult choice: Accept a "Great Reset" and risk losing the American way of life... or stand up and fight back to save what's left of the American dream. Jeff Brown, a member of a D.C.-based advocacy group, explains what every American must do before May 28th to preserve his assets and thrive.
Click here to see this emergency briefing before i